You searched for metabolic diseases - Page 3 of 62

News and Trends 9 Jan 2017

Top European VC and CRO fund Young Metabolic Disease Biotech

…in Berlin focusing on the treatment of metabolic diseases. The company has now raised €8M in Series A, led by Scottish biotech VC Epidarex Capital. Among the investors was also…

January 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Jan 2020

AstraZeneca Recruits RNA Biotech to Develop Metabolic Disease Therapies

The UK biotech MiNA Therapeutics has launched a collaboration with AstraZeneca to develop small activating RNA drugs, which could treat metabolic diseases using targets unreachable by current medications. According to…

January 7, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 19 Jun 2017

This Company Uses the Human Microbiome to Discover New Disease Mechanisms

…role in health and also cause unprecedented damage by starting inflammatory cascades, leading to numerous metabolic diseases. Finding the Link And so, while everybody else was focusing on the human…

June 19, 2017 - 5 minutesmins - By External Contributor

Best in Biotech 28 Nov 2024

Six antisense oligonucleotide companies shaping the future of genetic medicine

…that TGF-β is chronically elevated in many diseases, including ophthalmic and fibrotic diseases and cancer, and involved in their pathophysiology, it is thought to be an extremely versatile drug target…

November 28, 2024 - 10 minutesmins - By Willow Shah-Neville

News and Trends 28 Feb 2023

What’s happening on Rare Disease Day?

…are recent advancements in rare diseases? “There are more than 8,000 known rare diseases that affect over 300 million people globally. Yet only a small percentage of these have treatments…

February 28, 2023 - 8 minutesmins - By Jim Cornall

multiOmics Health metabolic disorders precision medicine

Opinion 11 Jul 2022

Precision medicine: the next big leap for metabolic disorders

…metabolic syndrome endotype requires operating at the molecular level. Other than a few rare genetic diseases, metabolic syndrome endotypes cannot be understood by looking purely at genetic mutations in the…

July 11, 2022 - 6 minutesmins - By External Contributor

metabolic disorders chaperones gain thx 1

News and Trends 20 Feb 2018

A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs

…genetic metabolic diseases, and a group of Swiss investors based in Lugano, Switzerland, including TiVenture – no financial data for the deal was disclosed. Gain Therapeutics is looking to apply…

February 20, 2018 - 3 minutesmins - By Alex Dale

Best in Biotech 5 Sep 2024

Six biotech companies that could revolutionize obesity treatments

…numerous investigational drugs to treat cancer, autoimmune diseases, and metabolic diseases like diabetes and obesity. The two notable obesity drugs of the company are HRS9531, a dual agonist of GLP-1/GIP…

September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 2 Apr 2025

Top biotech deals of March 2025

…be designed to potentially treat chronic diseases, including rare, autoimmune, and metabolic diseases. Syneron will receive $75 million in upfront and near-term payments as well as development and commercial milestones…

April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter

In Depth 4 Jan 2024

Can GLP-1 agonists, the miraculous obesity drugs, treat cardiovascular diseases?

Glucagon-like peptide 1 (GLP-1) agonists have proven their therapeutic mettle in treating metabolic diseases like diabetes and obesity, and now, researchers are studying their effects on cardiovascular disease. These drugs…

January 4, 2024 - 6 minutesmins - By Roohi Mariam Peter

Best in Biotech 19 Dec 2023

Nine biotech companies to watch in 2024

…a variety of diseases, including oncology, autoimmune diseases, blood disorders, and fibrosis. Capstan’s technology centers around targeted lipid nanoparticles (tLNPs) for delivering mRNA payloads to cells. This approach aims to…

December 19, 2023 - 12 minutesmins - By Jules Adam

In Depth 10 Sep 2025

When rare diseases are not so rare after all: A closer look at where and why this happens

…impact of these diseases and, in certain areas or communities around the world, some diseases that are considered rare globally are actually much more prevalent. With most rare diseases being…

September 10, 2025 - 11 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Top European VC and CRO fund Young Metabolic Disease Biotech

AstraZeneca Recruits RNA Biotech to Develop Metabolic Disease Therapies

This Company Uses the Human Microbiome to Discover New Disease Mechanisms

Six antisense oligonucleotide companies shaping the future of genetic medicine

What’s happening on Rare Disease Day?

Precision medicine: the next big leap for metabolic disorders

A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs

Six biotech companies that could revolutionize obesity treatments

Top biotech deals of March 2025

Can GLP-1 agonists, the miraculous obesity drugs, treat cardiovascular diseases?

Nine biotech companies to watch in 2024

When rare diseases are not so rare after all: A closer look at where and why this happens

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!